Top ASX Penny Stocks | All Ordinaries & ASX 300 Movers

Highlights

• Bisalloy Steel Group strengthens position in industrial materials through high-tensile steel

• Botanix Pharmaceuticals advances dermatology research with capital-backed expansion

• Champion Iron expands iron ore operations across North America with diversified strategy

The Australian share market continues to witness notable movement across smaller-cap names, particularly among penny stocks listed on the All Ordinaries and ASX 300. Several companies operating in steel, pharmaceuticals, and mining have recently surpassed the A$100 million market capitalisation mark, drawing attention for their financial structuring and operational reach.

While traditionally defined by lower share prices, these penny stocks now reflect broader market inclusion through increased scale and strategic positioning across global markets.

Bisalloy Steel Group (ASX:BIS) Broadens Global Steel Supply

Bisalloy Steel Group (ASX:BIS) is engaged in producing quenched and tempered steel plate products for wear-resistant, structural, and armour-grade applications. The company’s operations span multiple countries including Indonesia and Thailand, while maintaining a strong domestic base in Australia.

With a consistent focus on manufacturing high-performance steel products, the company has developed a firm standing in the industrial supply chain. It maintains a stable capital structure, with short-term assets aligned to cover operational obligations. No recent shareholder dilution and limited leverage further reinforce balance sheet efficiency. The business also shows consistency in earnings quality.

Botanix Pharmaceuticals (ASX:BOT) Deepens Focus on Dermatology Innovation

Botanix Pharmaceuticals (ASX:BOT) operates in the pharmaceutical research domain, focusing on skin-related treatments and antimicrobial development. While pre-revenue, the company has secured recent funding support to back its R&D programs, including dermatological product candidates targeting unmet clinical needs.

Despite current losses, the company’s asset profile allows it to address existing liabilities without pressure. Management changes and increased liquidity reflect strategic shifts toward accelerated clinical development. The business structure is characterised by a streamlined cost base and a focus on milestone-based project execution.

Champion Iron (ASX:CIA) Grows Resource Base in Canadian Territories

Champion Iron (ASX:CIA) oversees mining and development operations in North America, with a core focus on iron ore extraction and processing. Its assets are centred around iron concentrate production, a key commodity for global steelmaking.

Although earnings have fluctuated year-on-year, operational cash flow supports debt servicing and working capital requirements. The company has aligned its production strategy with export demand, tapping into infrastructure advantages in Quebec. Dividend coverage is not fully sustained by free cash flow, highlighting prioritised reinvestment into core mining activities.